Oragenics, Lantern Bioworks forge partnership for replacement-therapy assets

In a landmark collaboration, Oragenics, Inc. (NYSE American: OGEN) and Lantern Bioworks have sealed a groundbreaking partnership through a formal materials transfer agreement. This milestone ... Read More